Suppr超能文献

不同质膜结构域之间蛋白质运输的调控。跨胞吞小泡与顶端质膜融合过程中一种新型108,000蛋白的需求。

Control of protein traffic between distinct plasma membrane domains. Requirement for a novel 108,000 protein in the fusion of transcytotic vesicles with the apical plasma membrane.

作者信息

Sztul E, Colombo M, Stahl P, Samanta R

机构信息

Department of Molecular Biology, Princeton University, New Jersey 08544.

出版信息

J Biol Chem. 1993 Jan 25;268(3):1876-85.

PMID:8420962
Abstract

We have developed a cell-free system that reconstitutes the last step in transcytosis, i.e. the fusion of transcytotic transport vesicles with the apical plasma membrane (PM). Subcellular fractions containing transcytotic vesicles (the donor) or apical PM (the acceptor) were prepared from rat liver by sucrose density centrifugation. Fusion between the donor and acceptor fractions was measured by the conversion of the 120,000 transmembrane form of the polymeric IgA receptor (pIgA-R), an endogenous protein of transcytotic vesicles, to a processed fragment by a protease endogenous to the apical PM. Fusion occurred only at 37 degrees C and was critically dependent on the presence of ATP and cytosol. Fusion was inhibited by treating the in vitro fusion reaction with N-ethylmaleimide or by adding antibodies against N-ethylmaleimide-sensitive factor (NSF). We have previously identified a specific transcytotic vesicle-associated protein (TAP) and here show that TAP exists in both cytosolic and membrane-associated pools. Because of its exclusive interaction with transcytotic vesicles, we tested the involvement of TAP in distinct fusion processes. Removal of TAP inhibited fusion in an in vitro transcytotic fusion reaction but had no inhibitory effect in an in vitro endosome-endosome fusion system or in an in vitro intra-Golgi transport reaction. We propose that TAP represents part of the molecular machinery specifically involved in targeting and/or fusion of transcytotic vesicles with the apical PM.

摘要

我们开发了一种无细胞系统,该系统可重构转胞吞作用的最后一步,即转胞吞运输囊泡与顶端质膜(PM)的融合。通过蔗糖密度离心从大鼠肝脏制备含有转胞吞囊泡(供体)或顶端质膜(受体)的亚细胞组分。供体和受体组分之间的融合通过将转胞吞囊泡的内源性蛋白——聚合IgA受体(pIgA-R)的120,000跨膜形式,由顶端质膜内源性蛋白酶转化为加工片段来测定。融合仅在37℃时发生,并且关键依赖于ATP和胞质溶胶的存在。用N-乙基马来酰亚胺处理体外融合反应或添加抗N-乙基马来酰亚胺敏感因子(NSF)的抗体可抑制融合。我们之前鉴定了一种特定的转胞吞囊泡相关蛋白(TAP),此处表明TAP存在于胞质溶胶和膜相关组分中。由于其与转胞吞囊泡的排他性相互作用,我们测试了TAP在不同融合过程中的作用。去除TAP可抑制体外转胞吞融合反应中的融合,但对体外内体-内体融合系统或体外高尔基体内部运输反应没有抑制作用。我们提出TAP代表了专门参与转胞吞囊泡与顶端质膜靶向和/或融合的分子机制的一部分。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验